133 related articles for article (PubMed ID: 11720747)
1. Towards a biological staging model for operable non-small cell lung cancer.
O'Byrne KJ; Cox G; Swinson D; Richardson D; Edwards JG; Lolljee J; Andi A; Koukourakis MI; Giatromanolaki A; Gatter K; Harris AL; Waller D; Jones JL
Lung Cancer; 2001 Dec; 34 Suppl 2():S83-9. PubMed ID: 11720747
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Cox G; Louise Jones J; Andi A; Abrams KR; O'Byrne KJ
Lung Cancer; 2001 Dec; 34(3):417-26. PubMed ID: 11714539
[TBL] [Abstract][Full Text] [Related]
3. A biological staging model for operable non-small cell lung cancer.
Cox G; Jones JL; Andi A; Waller DA; O'Byrne KJ
Thorax; 2001 Jul; 56(7):561-6. PubMed ID: 11413356
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
5. Biological prognostic factors for early stage completely resected non-small cell lung cancer.
Cagini L; Monacelli M; Giustozzi G; Moggi L; Bellezza G; Sidoni A; Bucciarelli E; Darwish S; Ludovini V; Pistola L; Gregorc V; Tonato M
J Surg Oncol; 2000 May; 74(1):53-60. PubMed ID: 10861611
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables.
Swinson DE; Jones JL; Richardson D; Cox G; Edwards JG; O'Byrne KJ
Lung Cancer; 2002 Sep; 37(3):235-40. PubMed ID: 12234691
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
Swinson DE; Jones JL; Cox G; Richardson D; Harris AL; O'Byrne KJ
Int J Cancer; 2004 Aug; 111(1):43-50. PubMed ID: 15185341
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer.
Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
Eur J Surg Oncol; 2003 Oct; 29(8):654-7. PubMed ID: 14511612
[TBL] [Abstract][Full Text] [Related]
11. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
12. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
Toomey D; Smyth G; Condron C; Kay E; Conroy R; Foley D; Hong C; Hogan B; Toner S; McCormick P; Broe P; Kelly C; Bouchier-Hayes D
Cancer; 2001 Nov; 92(10):2648-57. PubMed ID: 11745200
[TBL] [Abstract][Full Text] [Related]
13. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
Wang Y; Zhang XR; Fu J; Tan W; Zhang W
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
[TBL] [Abstract][Full Text] [Related]
17. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Cox G; O'Byrne KJ
Br J Cancer; 2004 Oct; 91(7):1301-7. PubMed ID: 15365565
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
